SB

Shreelaxmi Bhat

Active Director Director DIN 10476083
DIN 10476083 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Shreelaxmi Bhat

Data last updated:

Shreelaxmi Bhat is a Director at Ayushvi Health Private Limited (since 2024). Ayushvi Health Private Limited reported revenue of ₹11.7 Lakh (FY 2025).

DIN 10476083
Primary Designation Director
First Appointment 22 Jan 2024
Oldest Company Age 2 yrs
Largest company Ayushvi Health Private Limited · ₹11.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ayushvi Health Private Limited U86901KA2024PTC183827
Director22 Jan 20242024₹11.7 Lakh (FY 2025)Active

Board colleagues of Shreelaxmi Bhat

NameDINCompanyDesignation
Megaravalli Rashmi Ramesh07661820Ayushvi Health Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ayushvi Health Private Limited
Premium access

Shareholding and investment profile for Shreelaxmi Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreelaxmi Bhat

Shreelaxmi Bhat currently holds 1 directorship: Ayushvi Health Private Limited (Director, since 22 Jan 2024, revenue ₹11.7 Lakh (FY 2025)).

Shreelaxmi Bhat was first appointed on 22 Jan 2024 as Director at Ayushvi Health Private Limited.

The current boards of Shreelaxmi Bhat's companies include Megaravalli Rashmi Ramesh (Ayushvi Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available